RBC Europe’s Insulet PODD Stock Holding History

RBC Europe’s Portfolio PODD Stock Details PODD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-40	Closed	-$11.4K	–	1008
2021 Q3	$11.4K	Hold	40	–	–	﹤0.01%	910
2021 Q2	$11K	Hold	40	–	–	﹤0.01%	935
2021 Q1	$10.4K	Hold	40	–	–	﹤0.01%	904
2020 Q4	$10.2K	Buy	+40	New	+$9.92K	﹤0.01%	873

Other funds holding PODD

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

DCP

D1 Capital Partners New York $34.8B AUM 11.34% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

RBC Europe's PODD Position: Q4 2021 in Review

RBC Europe sold out of Insulet (PODD) in Q4 2021, closing a stake of 40 shares — an estimated $11.4K sold.

RBC Europe first reported a position in PODD in Q4 2020 and held it in 4 quarters. The position peaked at $11.4K in Q3 2021. 475 funds tracked by Wall St. Rank hold PODD as of Q4 2021.

RBC Europe reported no remaining Insulet position as of Q4 2021 after selling out during the quarter.
RBC Europe sold 40 Insulet shares in Q4 2021, an estimated $11.4K.
RBC Europe first reported a position in Insulet in Q4 2020 and held it in 4 quarters.
RBC Europe's Insulet position peaked at $11.4K in Q3 2021.
475 funds tracked by Wall St. Rank held Insulet as of Q4 2021.

Based on RBC Europe's 13F filing for Q4 2021, filed 14 Nov 2022.